Novel biomarkers for cardiovascular risk

Area of Science:

• Biomedical research
• Cardiovascular medicine
• Biomarker discovery

Background:

• Cardiovascular diseases (CVD) are a leading cause of global morbidity and mortality.
• Accurate assessment of cardiovascular risk is crucial for effective prevention and management.
• Existing risk prediction models can be enhanced with novel biomarkers.

Purpose of the Study:

• To review the latest advancements in novel biomarkers for cardiovascular risk.
• To explore the utility of omics, imaging, and clinical data in cardiovascular risk assessment.
• To provide insights for improving the knowledge and management of cardiovascular risk.

Main Methods:

• Comprehensive literature review of recent studies on cardiovascular biomarkers.
• Analysis of emerging biomarkers from omics technologies (genomics, proteomics, metabolomics).
• Evaluation of advanced imaging techniques and clinical data integration for risk prediction.

Main Results:

• Identification of promising novel biomarkers across omics, imaging, and clinical data domains.
• Demonstration of the potential of these biomarkers to refine cardiovascular risk stratification.
• Highlighting the synergistic potential of integrating multi-modal data for enhanced prediction.

Conclusions:

• Novel biomarkers offer significant potential to improve cardiovascular risk prediction and patient outcomes.
• Integration of omics, imaging, and clinical data is key to advancing cardiovascular risk management.
• Further research and validation are needed to translate these biomarkers into clinical practice.